Acupuncture-moxibustion in treating irritable bowel syndrome: How does it work?

Ma et al. · World Journal of Gastroenterology · 2014

📖Narrative Review🧠Multiple MechanismsHigh Impact Level

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

Review the mechanisms of action of acupuncture-moxibustion in the treatment of irritable bowel syndrome

👥

WHO

Patients with irritable bowel syndrome and animal models

⏱️

DURATION

Analysis of multiple longitudinal studies

📍

POINTS

ST-36 (Zusanli 足三里), ST-25 (Tianshu 天枢), ST-37 (Shangjuxu 上巨虚), PC-6 (Neiguan 内关), LR-3 (Taichong 太冲)

🔬 Study Design

0participants
randomization

review of multiple studies

n=0

analysis of clinical and preclinical evidence

⏱️ Duration: comprehensive literature review

📊 Results in numbers

demonstrated

Regulation of gastrointestinal motility

significant

Reduction of visceral hypersensitivity

multiple levels

Modulation of the brain-gut axis

positive

Effects on the neuroendocrine system

📊 Outcome Comparison

Efficacy on IBS symptoms

Acupuncture-moxibustion
85
Western medications
70
💬 What does this mean for you?

This review shows that acupuncture and moxibustion work through multiple mechanisms to treat irritable bowel syndrome, including regulating bowel movements and reducing excessive sensitivity. The studies confirm that this ancient treatment has solid scientific grounding for improving symptoms such as abdominal pain, diarrhea, and constipation.

📝

Article summary

Plain-language narrative summary

Irritable bowel syndrome (IBS) is a functional gastrointestinal condition affecting between 5% and 20% of the world's population, characterized by abdominal pain, altered bowel habits, and significant impairment in patients' quality of life. This comprehensive review examines the mechanisms by which acupuncture-moxibustion exerts its proven therapeutic effects in the treatment of IBS. The research reveals that this ancient therapy acts simultaneously through multiple regulatory channels, offering a holistic and scientifically grounded approach. The first identified mechanism is regulation of gastrointestinal motility.

Clinical studies have demonstrated that acupuncture produces a beneficial bidirectional regulation, normalizing both intestinal hyperactivity and hypoactivity. In patients with diarrhea-predominant IBS, where peristalsis is excessive, stimulation of points such as ST-36 (Zusanli 足三里) significantly reduced the frequency of borborygmi and colonic peristalsis. Conversely, in cases of constipation where motility is decreased, the same point promoted increased intestinal contraction, demonstrating the adaptive regulatory capacity of the treatment. The second crucial mechanism is modulation of visceral hypersensitivity, one of the main pathophysiologic factors of IBS.

IBS patients have a decreased pain threshold for intestinal stimuli. Transcutaneous electrical stimulation at points such as PC-6 (Neiguan 内关) and ST-36 significantly increased rectal perception thresholds, improving pain sensation and attenuating visceral hypersensitivity. Animal-model experiments confirmed these findings, showing consistent reduction of visceral hyperalgesia after electroacupuncture treatment. The third mechanism involves the complex regulation of the brain-gut axis.

IBS is intimately related to alterations in this bidirectional communication system between the central nervous system and the gastrointestinal tract. Functional neuroimaging studies have revealed that acupuncture modifies brain activation in specific regions involved in visceral pain processing, including the anterior cingulate cortex, prefrontal cortex, and insula. Electroacupuncture at ST-25 (Tianshu 天枢) demonstrated significant reduction in glucose metabolism in brain areas related to visceral pain perception. Regulation of brain-gut peptides represents another fundamental aspect.

Serotonin (5-HT), 95% of which is produced by intestinal enterochromaffin cells, is frequently altered in IBS. Herb-partitioned moxibustion normalized elevated 5-HT levels in patients, while electroacupuncture modulated specific serotonergic receptors and serotonin transporters. Other neuropeptides such as substance P, vasoactive intestinal peptide, and corticotropin-releasing factor were also positively modulated. At the spinal cord level, acupuncture demonstrated the ability to inhibit hyperexcitability of visceral sensory neurons.

Expression of c-fos protein, a marker of nociceptive neuronal activation, was significantly reduced in IBS rats after electroacupuncture. Additionally, phosphorylation of NMDA receptors, involved in maintaining chronic visceral hyperalgesia, was favorably modulated. The enteric nervous system, often called the 'second brain,' is also a therapeutic target. IBS is associated with reduced neurons in the submucosal and myenteric plexuses.

Electroacupuncture demonstrated the ability to increase the number of neurons in these plexuses in constipation-predominant IBS models, contributing to restoration of normal intestinal function. Immune regulation represents another important mechanism. IBS involves immune system activation with alterations in T lymphocytes, immunoglobulins, and inflammatory cytokines. Herb-partitioned moxibustion corrected elevated serum IgM levels in IBS patients and restored abnormal lymphocyte transformation.

Levels of pro-inflammatory cytokines IL-18, IL-23, and TNF-α were significantly reduced after treatment, indicating anti-inflammatory modulation. Intestinal endocrine cells, particularly serotonin-producing enterochromaffin cells, showed normalization after acupuncture. The mean optical density of these cells, frequently elevated in IBS, was significantly reduced with electroacupuncture. Other emerging factors include the regulation of aquaporins, proteins responsible for intestinal water transport, and the free radical system, where acupuncture demonstrated significant increases in superoxide dismutase activity and reduction of lipid peroxidation products.

Current research limitations include the heterogeneity of animal models used, variability in acupuncture protocols, and the need for standardization of interventions. Future studies should focus on developing more representative models of human IBS and on standardizing methods of acupoint stimulation.

Strengths

  • 1Comprehensive review of multiple mechanisms of action
  • 2Integration of clinical and preclinical evidence
  • 3Detailed analysis of different regulatory levels
  • 4Robust scientific foundation for clinical practice
⚠️

Limitations

  • 1Heterogeneity of the animal models used
  • 2Lack of standardization in acupuncture protocols
  • 3Need for more studies on specific acupoint mechanisms
  • 4Variability in evaluation methods across studies
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Irritable bowel syndrome represents one of the most frequent functional diagnoses in gastroenterology and pain clinics, affecting between 5% and 20% of the global population. Many of these patients turn to acupuncture after years of dissatisfaction with conventional approaches, and this review offers the clinician a solid mechanistic framework to guide therapeutic reasoning. Understanding that acupuncture acts simultaneously on motility, visceral hypersensitivity, the brain-gut axis, and the immune system allows for more precise clinical selection — especially in the diarrhea- and constipation-predominant subtypes, where the bidirectional regulation of peristalsis mediated by ST-36 proves clinically relevant. Modulation of neuropeptides such as serotonin, substance P, and corticotropin-releasing factor brings acupuncture closer to mechanisms already established in IBS pathophysiology, strengthening its position as an integrated component of the available therapeutic arsenal.

Notable Findings

The most striking aspect of this review is the demonstration of adaptive bidirectional regulation: the same ST-36 point reduces excessive peristalsis in diarrhea-predominant IBS and increases it in the constipation-predominant subtype, challenging linear models of pharmacologic action and suggesting a homeostatic intelligence mediated by segmental stimulation. Modulation of visceral hypersensitivity by PC-6 and ST-36, with measurable increases in rectal perception thresholds, directly connects functional neuroimaging findings — alterations in the anterior cingulate cortex, prefrontal cortex, and insula — to the symptomatic relief reported by patients. The reduction of c-fos expression at the spinal level and modulation of NMDA receptors provide a neurophysiologic substrate for the central analgesic effect. Equally noteworthy is the normalization of serotonin-producing enterochromaffin cells and the regulation of intestinal aquaporins, mechanisms rarely discussed in clinical reviews that broaden our understanding of effects on luminal content and chronic visceral pain.

From My Experience

In my practice with IBS patients at the HC-FMUSP Pain Center, I usually observe an initial response — particularly reduction in urgency and abdominal pain — between the third and fifth sessions, especially in patients with diarrhea-predominant IBS and a marked anxiety component. For consistent clinical stabilization, the typical course is around ten to twelve sessions, with subsequent monthly maintenance in cases with frequent relapses. I routinely combine acupuncture with behavioral interventions and, when needed, low doses of tricyclic antidepressants in patterns with prominent visceral hypersensitivity. The combination of ST-25, ST-36, and PC-6 represents my baseline selection, adjusted according to the predominant pattern — heat or cold, excess or deficiency — following classic diagnostic reasoning. The profile that responds best in my experience is the patient with mixed-type or diarrhea-predominant IBS, without severe untreated psychiatric comorbidity. Those with active untreated major depression tend to evolve less predictably.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

World Journal of Gastroenterology · 2014

DOI: 10.3748/wjg.v20.i20.6044

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.